ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 OS in mHSPC Treated With Enzalutamide + ADT by High/Low Disease Volume and Progression to (de Novo) mHSPC (M0/M1 at Diagnosis): Post Hoc Analysis of the Phase 3 ARCHES Trial
By
ASCO Genitourinary Cancers Symposium
FEATURING
Andrew Armstrong
By
ASCO Genitourinary Cancers Symposium
FEATURING
Andrew Armstrong
53 views
March 2, 2022
Comments 0
Login to view comments.
Click here to Login
Videos